Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

Author： The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.81, Iss.1, 2004-01, pp. : 19-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Long-term response to naltrexone in polycystic ovary syndrome?

By Cagnacci A. Paoletti A.M.

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 659-659

Elsevier

Access to resources Recommend Favorite

Long-term response to naltrexone in polycystic ovary syndrome? Reply of the authors

By Fruzzetti F. Bersi C. Parrini D. Ricci C. Genazzani A.R.

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 659-660

Elsevier

Access to resources Recommend Favorite

Insulin resistance and the long-term consequences of polycystic ovary syndrome

By Bhathena R. K.

Journal of Obstetrics & Gynaecology, Vol. 31, Iss. 2, 2011-02 ,pp. : 105-110

Informa Healthcare

Access to resources Recommend Favorite

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome

By Fruzzetti F. Bersi C. Parrini D. Ricci C. Genazzani A.R.

Fertility and Sterility, Vol. 77, Iss. 5, 2002-05 ,pp. : 936-944

Elsevier

Access to resources Recommend Favorite

Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors

By Lakhani K Prelevic GM Seifalian AM Atiomo WU Hardiman P

Journal of Obstetrics & Gynaecology, Vol. 24, Iss. 6, 2004-09 ,pp. : 613-621

Informa Healthcare

Access to resources Recommend Favorite